Disease-modifying therapy prescription patterns in people with multiple sclerosis by age

BACKGROUND: Disease-modifying therapies (DMTs) for multiple sclerosis (MS) are approved for their ability to reduce disease activity, namely clinical relapses and signal changes on magnetic resonance imaging (MRI). Disease activity appears age dependent. Thus, the greatest benefit would be expected...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yinan, Salter, Amber, Jin, Shan, Culpepper, William J., Cutter, Gary R., Wallin, Mitchell, Stuve, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020738/
https://www.ncbi.nlm.nih.gov/pubmed/33868459
http://dx.doi.org/10.1177/17562864211006499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020738/
https://www.ncbi.nlm.nih.gov/pubmed/33868459
http://dx.doi.org/10.1177/17562864211006499

Ejemplares similares